MedTrace Logo

Endovascular Thrombectomy in COVID-19 Infected Patients

NCT04406090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-07-29

No results posted yet for this study

Summary

About 5% of COVID-19 patients may present symptoms related to acute ischemic stroke (AIS). Treatment-management and outcomes related to mechanical thrombectomy (MT) for COVID-19 infected patients harboring large vessel occlusion is largely unknown.

This multicentric study aims to investigate morbidity, mortality and neurological outcomes after MT performed in patients with COVID-19 infection.

Conditions

Interventions

OTHER

Mechanical Trombectomy

Stent retriever for treatment of cerebral arterial occlusions

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Federico Cagnazzo, MD PhD · UH Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04406090 on ClinicalTrials.gov